Joanne L. Viney - 12 May 2021 Form 4 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FNCH	Stock Option (right to buy)	Award	$0	+23,419		$0.000000	23,419	12 May 2021	Common Stock	23,419	$12.27	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	One-third (1/3rd) of the shares subject to the option vest on May 12, 2022, and the remaining shares subject to the option shall vest in twenty-four (24) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.